HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wells syndrome

A rare type of eosinophilia that primarily affects the skin. It is characterized by a skin rash that is often proceeded by an itching or burning sensation. The rash may persist for 4 to 8 weeks and can recur years later.
Also Known As:
Bullous cellulitis with eosinophilia; Eosinophilic cellulitis; Wells' syndrome
Networked: 103 relevant articles (10 outcomes, 1 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Wells syndrome
2. Neoplasms (Cancer)
3. Hearing Loss (Hearing Impairment)
4. B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
5. Churg-Strauss Syndrome (Allergic Angiitis)

Experts

1. Junkins-Hopkins, Jacqueline M: 2 articles (08/2022 - 12/2003)
2. Yamamoto, Toshiyuki: 2 articles (11/2020 - 03/2020)
3. Simon, Dagmar: 2 articles (01/2011 - 04/2003)
4. Simon, Hans-Uwe: 2 articles (01/2011 - 04/2003)
5. Kaufmann, Roland: 2 articles (07/2005 - 05/2003)
6. Ludwig, Ralf J: 2 articles (07/2005 - 05/2003)
7. Wolter, Manfred: 2 articles (07/2005 - 05/2003)
8. Zollner, Thomas M: 2 articles (07/2005 - 05/2003)
9. Bleicher, Isaac D: 1 article (11/2022)
10. Reshef, Edith R: 1 article (11/2022)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Wells syndrome:
1. mepolizumabIBA
2. Omalizumab (Xolair)FDA Link
3. dupilumabIBA
4. Metronidazole (Metric)FDA LinkGeneric
5. GlycosidesIBA
6. CortisoneFDA Link
7. Antiviral Agents (Antivirals)IBA
8. Mometasone Furoate (Nasonex)FDA LinkGeneric
9. levocetirizineFDA LinkGeneric
10. Antigen-Antibody Complex (Immune Complex)IBA

Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Cochlear Implantation
4. Colectomy
5. Tattooing